Lynne N. Ward - 15 Sep 2021 Form 4 Insider Report for MERIT MEDICAL SYSTEMS INC (MMSI)

Role
Director
Signature
/s/ Brian G. Lloyd, Attorney-in-Fact
Issuer symbol
MMSI
Transactions as of
15 Sep 2021
Net transactions value
-$167,913
Form type
4
Filing time
17 Sep 2021, 15:53:39 UTC
Previous filing
21 Jun 2021
Next filing
26 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MMSI Common Stock, No Par Value Options Exercise $512,317 +14,867 +209% $34.46 21,969 15 Sep 2021 Direct
transaction MMSI Common Stock, No Par Value Sale $680,230 -9,470 -43% $71.83 12,499 15 Sep 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MMSI Non-qualified stock options (right to buy) Options Exercise $0 -14,867 -67% $0.000000 7,433 15 Sep 2021 Common Stock 14,867 $34.46 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.538 to $72.02, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F2 The total reported in Column 5 of Table I includes 4,188 fully-vested restricted stock units and 2,914 restricted stock units that vest on June 17, 2022. Vesting of restricted stock units is subject to continued service to the issuer through the vesting date.
F3 Becomes exercisable in equal annual installments of 33% commencing 08/28/2020.